Op­er­a­tion Warp Speed re­dux: HHS awards $1.4B to de­vel­op next-gen Covid-19 drugs and vac­cines

HHS on Tues­day an­nounced it’s pump­ing $1.4 bil­lion in gov­ern­ment funds in­to next-gen Covid-19 med­ical prod­ucts in the pipeline, in­clud­ing $326 mil­lion to Re­gen­eron to help de­vel­op a Covid-19 mon­o­clon­al an­ti­body.

The an­nounce­ment is the first pub­lic step for­ward for Project NextGen, which aims to spend $5 bil­lion on de­vel­op­ing new Covid-19 ther­a­pies and vac­cines, the Biden ad­min­is­tra­tion an­nounced in May.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER